CVRX News and Press, CVRx Inc. From 08/04/25

Kyndryl Holdings Inc. (KD) is expected to report $0.25 for Q1 2026 Bruker Corporation (BRKR) is expected to report $0.33 for Q2 2025 Vornado Realty Trust (VNO) is expected to report $0.53 for Q2 2025 Diamondback Energy Inc. (FANG) is expected to report $2.63 for Q2 2025 Freightcar...

CVRx Inc. (CVRX) is expected to report $-0.52 for Q2 2025

2025-08-03 18:45:28 ET CVRx, Inc. (CVRX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 9.39%. The average open to low on the day of earnings was -9.99%. The average open to close on th...

2025-08-03 18:40:29 ET CVRx, Inc. (CVRX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CVRX stock price following earnings has averaged ±9.61% , with a median of 6.29%. The singl...

MINNEAPOLIS, July 29, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management...

MINNEAPOLIS, July 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to re...

2025-07-16 16:08:29 ET More on CVRx CVRx: Sell-Off Ignores Its True Potential CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript CVRx downgraded at J.P. Morgan after Q1 sales miss Seeking Alpha’s Quant Rating on CVRx Historical earni...

MINNEAPOLIS, July 16, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services (CMS) has proposed to keep the Barostim implant procedure as part of the New Technology A...

2025-07-02 04:02:35 ET Summary Read the full article on Seeking Alpha For further details see: CVRx: Sell-Off Ignores Its True Potential

MINNEAPOLIS, May 28, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management ...